Carol Craig - Sidus Space Chairwoman, Founder
| SIDU Stock | USD 1.67 0.03 1.76% |
Insider
Carol Craig is Chairwoman, Founder of Sidus Space
| Age | 57 |
| Address | 150 North Sykes Creek Parkway, Merritt Island, FL, United States, 32953 |
| Phone | 321 450 5633 |
| Web | https://www.sidusspace.com |
Carol Craig Latest Insider Activity
Tracking and analyzing the buying and selling activities of Carol Craig against Sidus Space stock is an integral part of due diligence when investing in Sidus Space. Carol Craig insider activity provides valuable insight into whether Sidus Space is net buyers or sellers over its current business cycle. Note, Sidus Space insiders must abide by specific rules, including filing SEC forms every time they buy or sell Sidus Space'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Carol Craig over a month ago Acquisition by Carol Craig of 135000 shares of Sidus Space at 2.57 subject to Rule 16b-3 | ||
Carol Craig over a year ago Purchase by Carol Craig of 500000 shares of Sidus Space |
Sidus Space Management Efficiency
The company has return on total asset (ROA) of (0.4088) % which means that it has lost $0.4088 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.7063) %, meaning that it created substantial loss on money invested by shareholders. Sidus Space's management efficiency ratios could be used to measure how well Sidus Space manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.91 in 2025. Return On Capital Employed is likely to gain to -1.92 in 2025. Change To Liabilities is likely to gain to about 2.6 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 9.1 M in 2025.Similar Executives
| Found 11 records | INSIDER Age | ||
| Jason Davis | Virax Biolabs Group | 53 | |
| Michael Myers | Quoin Pharmaceuticals Ltd | 63 | |
| Denise Carter | Quoin Pharmaceuticals Ltd | 56 | |
| Shun Hui | Intelligent Living Application | 35 | |
| Cameron Shaw | Virax Biolabs Group | 37 | |
| Wei Zhong | Intelligent Living Application | 40 | |
| Ching Wong | Intelligent Living Application | 56 | |
| Gordon JD | Quoin Pharmaceuticals Ltd | 61 | |
| Po Hui | Intelligent Living Application | 73 | |
| James Foster | Virax Biolabs Group | 40 | |
| Tomasz George | Virax Biolabs Group | 40 | |
Management Performance
| Return On Equity | -1.71 | ||||
| Return On Asset | -0.41 |
Sidus Space Leadership Team
Elected by the shareholders, the Sidus Space's board of directors comprises two types of representatives: Sidus Space inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sidus. The board's role is to monitor Sidus Space's management team and ensure that shareholders' interests are well served. Sidus Space's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sidus Space's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Billy CFE, Chief officer | ||
| John Curry, Chief Officer | ||
| Jamie Adams, CTO Director | ||
| Jessica Curry, Senior Chain | ||
| John Roy, Director Resources | ||
| Teresa Burchfield, Chief Officer | ||
| Val Ojdanic, Chief Officer | ||
| Mark Mikolajczyk, Director Operations | ||
| Adarsh Parekh, Chief Officer | ||
| Carol Craig, Chairwoman, Founder | ||
| Richard Kube, Chief Officer |
Sidus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sidus Space a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.71 | ||||
| Return On Asset | -0.41 | ||||
| Profit Margin | (2.92) % | ||||
| Operating Margin | (1.70) % | ||||
| Current Valuation | 30.67 M | ||||
| Shares Outstanding | 14.26 M | ||||
| Shares Owned By Insiders | 1.14 % | ||||
| Shares Owned By Institutions | 20.26 % | ||||
| Number Of Shares Shorted | 1.16 M | ||||
| Price To Book | 2.63 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sidus Stock Analysis
When running Sidus Space's price analysis, check to measure Sidus Space's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sidus Space is operating at the current time. Most of Sidus Space's value examination focuses on studying past and present price action to predict the probability of Sidus Space's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sidus Space's price. Additionally, you may evaluate how the addition of Sidus Space to your portfolios can decrease your overall portfolio volatility.